mobiCARE Cardio

Published by: Seers Technology Co

Description

건강검진시 24시간 이상 심전도를 측정을 하여 전문가의 부정맥 판독을 도와주는 앱입니다.
mobiCARE Cardio 는 의사가 부정맥 관련 심질환을 정확한 데이터에 근거하여 진단할수 있도록 도와주는 서비스입니다. 이 앱은 MC100 바이오 패치와 연동하여 심전도를 측정합니다.
고혈압, 당뇨, 고지혈증 등 심혈관 질환 위험 요소를 한 개 이상 가지고 있는 사람이나 이미 심혈관 질환을 않고 있는 사람들에게 정기적 모니터링과 검진을 통한 조기 발견 및 관리는 선택이 아닌 필수 입니다.
mobiCARE Cardio는 지속적인 모니터링으로 심방 세동과 같은 부정맥을 찾아내는 데에 최적화된 솔루션입니다.
mobiCARE Cardio솔루션은 바이오 패치, 모바일 애플리케이션, AI알고리즘 베이스의 ECG데이터분석 클라우드, 의료진의 판독을 보조하는 웹 서비스로 구성되어 있습니다.
Hide Show More...

Screenshots

mobiCARE Cardio FAQ

  • Is mobiCARE Cardio free?

    Yes, mobiCARE Cardio is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is mobiCARE Cardio legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does mobiCARE Cardio cost?

    mobiCARE Cardio is free.

  • What is mobiCARE Cardio revenue?

    To get estimated revenue of mobiCARE Cardio app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating

5 out of 5

5 ratings in South Korea

5 star
5
4 star
0
3 star
0
2 star
0
1 star
0
Ratings History

mobiCARE Cardio Reviews

App doesn't have any reviews yet

Store Rankings

Ranking History
Category Rankings
App is not ranked yet

Keywords

mobiCARE Cardio Installs

Last 30 days

mobiCARE Cardio Revenue

Last 30 days

mobiCARE Cardio Revenue and Downloads

Gain valuable insights into mobiCARE Cardio performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English, Korean
Recent release
1.0.0 (4 years ago )
Released on
Sep 17, 2020 (4 years ago )
Also available in
South Korea, Canada, United States
Last Updated
6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.